Back
Array Technologies Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
28
ARRY
Array Technologies
Last Price:
$6.39
Seasonality Move:
-24.05%
Buy
56
BMRN
Biomarin Pharmaceutical
Last Price:
$62.05
Seasonality Move:
-2.99%
Sell
28
Array Technologies (ARRY)
is a Sell
Is Array Technologies a Buy, Sell or Hold?
-
The current Array Technologies [ARRY] share price is $6.82. The Score for ARRY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
ARRY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $62.53. The Score for BMRN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARRY Stock Price Chart
What is Array Technologies's stock price today?
-
The Array Technologies share price today is $6.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARRY is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $62.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
ARRY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.23 | Buy |
Relative Strength Index (14 RSI): | 56.03 | Buy |
Chaikin Money Flow: | 902949 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.61 - 6.81) | Buy |
Bollinger Bands (100): | (5.99 - 6.95) | Buy |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.97 | Sell |
Relative Strength Index (14 RSI): | 38.23 | Sell |
Chaikin Money Flow: | 730635 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.64 - 67.56) | Sell |
Bollinger Bands (100): | (62.38 - 77.6) | Sell |
ARRY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.77 | Buy |
20-day SMA: | 6.41 | Buy |
50-day SMA: | 6.31 | Buy |
200-day SMA: | 8.9 | Sell |
8-day EMA: | 6.81 | Buy |
20-day EMA: | 6.54 | Buy |
50-day EMA: | 6.46 | Buy |
200-day EMA: | 8.83 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.18 | Sell |
20-day SMA: | 65.52 | Sell |
50-day SMA: | 65.42 | Sell |
200-day SMA: | 77.1 | Sell |
8-day EMA: | 63.51 | Sell |
20-day EMA: | 64.87 | Sell |
50-day EMA: | 66.39 | Sell |
200-day EMA: | 75.12 | Sell |
Array Technologies Earnings Growth & ARRY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.14 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.02 per share.
Array Technologies Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |